Ovid Therapeutics Inc.

OVID

$2.94

Name : Ovid Therapeutics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $444,025,152.00

EPSttm : -0.23

Ovid Therapeutics Inc.

$2.94

5.38%

$0.15

OVID — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

7.98

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

-0.15

EPS Last/This Y

-0.19

EPS This/Next Y

-0.05

Price

2.8

Target Price

5.25

Analyst Recom

Performance Q

67.07

Upside

-221.1%

Beta

0.08

Ticker: OVID

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	OVID	2.015	0.08	7.84	4827
2026-03-18	OVID	2.295	0.07	0.25	4787
2026-03-19	OVID	2.295	0.10	1.07	5691
2026-03-20	OVID	2.615	0.18	0.02	6075
2026-03-23	OVID	2.54	0.20	0.66	5061
2026-03-24	OVID	2.4	0.24	1.09	5125
2026-03-25	OVID	2.39	0.24	0.16	5128
2026-03-26	OVID	2.45	0.24	0.00	5180
2026-03-27	OVID	2.29	0.24	1.11	5171
2026-03-30	OVID	2.11	0.24	106.78	5183
2026-03-31	OVID	2.21	0.46	0.00	6132
2026-04-01	OVID	2.16	0.44	0.92	6318
2026-04-02	OVID	2.2	0.45	0.96	6449
2026-04-06	OVID	2.32	0.48	0.01	6558
2026-04-07	OVID	2.56	0.46	0.01	6723
2026-04-08	OVID	2.62	0.47	0.03	6708
2026-04-09	OVID	2.88	0.46	0.02	6755
2026-04-10	OVID	2.75	0.48	1.27	6654
2026-04-13	OVID	2.8	0.50	0.08	6796
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	OVID	2.01	24.6	-18.0	-0.45
2026-03-18	OVID	2.33	24.6	-26.3	-0.45
2026-03-19	OVID	2.30	24.6	-16.7	-0.45
2026-03-20	OVID	2.62	24.6	-24.4	-0.45
2026-03-23	OVID	2.54	40.0	-14.2	-0.37
2026-03-24	OVID	2.40	40.0	-11.0	-0.37
2026-03-25	OVID	2.39	40.0	-14.1	-0.37
2026-03-26	OVID	2.45	40.0	-16.1	-0.37
2026-03-27	OVID	2.30	40.0	-10.0	-0.37
2026-03-30	OVID	2.11	17.9	-8.9	-0.43
2026-03-31	OVID	2.21	17.9	-17.9	-0.43
2026-04-01	OVID	2.16	17.9	-12.9	-0.43
2026-04-02	OVID	2.20	17.9	-15.7	-0.43
2026-04-06	OVID	2.32	17.9	-18.0	-0.43
2026-04-07	OVID	2.57	17.9	-21.8	-0.43
2026-04-08	OVID	2.61	17.9	-15.5	-0.43
2026-04-09	OVID	2.88	17.9	-21.6	-0.43
2026-04-10	OVID	2.76	17.9	-11.6	-0.43
2026-04-13	OVID	2.80	24.3	-15.6	-0.42
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	OVID	-0.14	14.16	4.41
2026-03-18	OVID	-0.14	14.16	4.41
2026-03-19	OVID	-0.14	14.16	4.41
2026-03-20	OVID	-0.14	14.16	4.41
2026-03-23	OVID	-0.14	11.98	4.35
2026-03-24	OVID	-0.14	11.98	4.35
2026-03-25	OVID	-0.14	11.98	4.66
2026-03-26	OVID	-0.14	11.98	4.66
2026-03-27	OVID	-0.14	11.98	4.66
2026-03-30	OVID	-0.14	11.98	4.66
2026-03-31	OVID	-0.14	11.98	4.66
2026-04-01	OVID	-0.14	11.98	4.66
2026-04-02	OVID	-0.14	11.98	4.66
2026-04-06	OVID	-0.14	11.98	4.66
2026-04-07	OVID	-0.14	11.98	4.66
2026-04-08	OVID	-0.14	11.98	4.66
2026-04-09	OVID	-0.14	11.98	4.66
2026-04-10	OVID	-0.14	11.98	4.66
2026-04-13	OVID	-0.14	12.10	7.98
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.06

Avg. EPS Est. Current Quarter

-0.12

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

-0.14

Institutional Transactions

12.1

Beta

0.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

41.8

Max Drawdown 5-Year %

-94.3

Target Price

5.25

P/E

Forward P/E

PEG

P/S

50.75

P/B

2.78

P/Free Cash Flow

EPS

-0.26

Average EPS Est. Cur. Y

-0.42

EPS Next Y. (Est.)

-0.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-240.11

Relative Volume

1.15

Return on Equity vs Sector %

-40.7

Return on Equity vs Industry %

-24.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

-15.6

◆ OVID Healthcare

$2.79

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

6/25

Volume

4/15

Valuation

8/20

TP/AR

4/10

Options

7/10

RSI

67.4

Range 1M

73%

Sup Dist

3.9%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

15/25

Growth

14/30

Estimates

3/20

Inst/Vol

11/15

Options

7/10

EPS Yr

-114.1%

EPS NY

-19.4%

52W%

88.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +88.2% upside

Quality

6/30

Valuation

14/30

Growth

9/25

Stability

7/10

LT Trend

4/5

Upside

+88.2%

Quality

Ovid Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 23

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

OVID

Latest News

—

Caricamento notizie per OVID…

stock quote shares OVID – Ovid Therapeutics Inc. Stock Price stock today

news today OVID – Ovid Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch OVID – Ovid Therapeutics Inc. yahoo finance google finance

stock history OVID – Ovid Therapeutics Inc. invest stock market

stock prices OVID premarket after hours

ticker OVID fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: OVID

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y